130 related articles for article (PubMed ID: 9434957)
21. PTEN and prostate cancer.
Facher EA; Law JC
J Med Genet; 1998 Sep; 35(9):790. PubMed ID: 9733047
[No Abstract] [Full Text] [Related]
22. Mutation analysis of the putative tumor suppressor PTEN/MMAC1 in human ovarian cancer.
Yokomizo A; Tindall DJ; Hartmann L; Jenkins RB; Smith DI; Liu W
Int J Oncol; 1998 Jul; 13(1):101-5. PubMed ID: 9625810
[TBL] [Abstract][Full Text] [Related]
23. [PTEN tumor suppressor: functions as a lipid phosphatase].
Maehama T; Dixon JE
Tanpakushitsu Kakusan Koso; 2000 Oct; 45(14):2405-14. PubMed ID: 11051842
[No Abstract] [Full Text] [Related]
24. PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.
Tohma Y; Gratas C; Biernat W; Peraud A; Fukuda M; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1998 Jul; 57(7):684-9. PubMed ID: 9690672
[TBL] [Abstract][Full Text] [Related]
25. PTEN germ-line mutations in juvenile polyposis coli.
Olschwang S; Serova-Sinilnikova OM; Lenoir GM; Thomas G
Nat Genet; 1998 Jan; 18(1):12-4. PubMed ID: 9425889
[No Abstract] [Full Text] [Related]
26. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.
Nelen MR; van Staveren WC; Peeters EA; Hassel MB; Gorlin RJ; Hamm H; Lindboe CF; Fryns JP; Sijmons RH; Woods DG; Mariman EC; Padberg GW; Kremer H
Hum Mol Genet; 1997 Aug; 6(8):1383-7. PubMed ID: 9259288
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme.
Fults D; Pedone CA; Thompson GE; Uchiyama CM; Gumpper KL; Iliev D; Vinson VL; Tavtigian SV; Perry WL
Int J Oncol; 1998 Apr; 12(4):905-10. PubMed ID: 9499454
[TBL] [Abstract][Full Text] [Related]
28. Alterations of the MMAC1/PTEN gene in lymphoid malignancies.
Grønbaek K; Zeuthen J; Guldberg P; Ralfkiaer E; Hou-Jensen K
Blood; 1998 Jun; 91(11):4388-90. PubMed ID: 9596690
[No Abstract] [Full Text] [Related]
29. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q.
Boström J; Cobbers JM; Wolter M; Tabatabai G; Weber RG; Lichter P; Collins VP; Reifenberger G
Cancer Res; 1998 Jan; 58(1):29-33. PubMed ID: 9426052
[TBL] [Abstract][Full Text] [Related]
30. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN.
Stambolic V; Suzuki A; de la Pompa JL; Brothers GM; Mirtsos C; Sasaki T; Ruland J; Penninger JM; Siderovski DP; Mak TW
Cell; 1998 Oct; 95(1):29-39. PubMed ID: 9778245
[TBL] [Abstract][Full Text] [Related]
31. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV
Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379
[TBL] [Abstract][Full Text] [Related]
32. Landscaping the cancer terrain.
Kinzler KW; Vogelstein B
Science; 1998 May; 280(5366):1036-7. PubMed ID: 9616081
[No Abstract] [Full Text] [Related]
33. PTEN and myotubularins: families of phosphoinositide phosphatases.
Taylor GS; Dixon JE
Methods Enzymol; 2003; 366():43-56. PubMed ID: 14674238
[No Abstract] [Full Text] [Related]
34. Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.
Cheney IW; Johnson DE; Vaillancourt MT; Avanzini J; Morimoto A; Demers GW; Wills KN; Shabram PW; Bolen JB; Tavtigian SV; Bookstein R
Cancer Res; 1998 Jun; 58(11):2331-4. PubMed ID: 9622068
[TBL] [Abstract][Full Text] [Related]
35. Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines.
Tsao H; Zhang X; Benoit E; Haluska FG
Oncogene; 1998 Jul; 16(26):3397-402. PubMed ID: 9692547
[TBL] [Abstract][Full Text] [Related]
36. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Guldberg P; thor Straten P; Birck A; Ahrenkiel V; Kirkin AF; Zeuthen J
Cancer Res; 1997 Sep; 57(17):3660-3. PubMed ID: 9288767
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN.
Tamura M; Gu J; Matsumoto K; Aota S; Parsons R; Yamada KM
Science; 1998 Jun; 280(5369):1614-7. PubMed ID: 9616126
[TBL] [Abstract][Full Text] [Related]
38. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.
Tashiro H; Blazes MS; Wu R; Cho KR; Bose S; Wang SI; Li J; Parsons R; Ellenson LH
Cancer Res; 1997 Sep; 57(18):3935-40. PubMed ID: 9307275
[TBL] [Abstract][Full Text] [Related]
39. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas.
Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J
Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766
[TBL] [Abstract][Full Text] [Related]
40. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Liaw D; Marsh DJ; Li J; Dahia PL; Wang SI; Zheng Z; Bose S; Call KM; Tsou HC; Peacocke M; Eng C; Parsons R
Nat Genet; 1997 May; 16(1):64-7. PubMed ID: 9140396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
